GlaxoSmithKline: A merger too far?
This teaching case study summarises events leading to the creation of a global pharmaceutical giant and the early years of its performance while inviting readers to consider the process of growth through mergers and acquisitions as a general strategy. The case also looks at the expectations, deliberations and motivation of managers and stakeholders in doing so. The case invites readers to reflect on whether more mergers are to be the future of GlaxoSmithKline.
When requesting a correction, please mention this item's handle: RePEc:wpa:wuwpgt:0405003. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (EconWPA)
If references are entirely missing, you can add them using this form.